CD274 and sarcoma: Regarding immunotherapeutic targets, most sarcomas with simple genomes show little to no expression of PD-L1 or infiltration of T cells expressing PD-1 or cytotoxic T lymphocyte antigen 4 (CTLA-4) (Table 1) [30,32,44,59,60].